Novocure to Report First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo
April 3, 2024 5:14 AM EDTWells Fargo analyst Larry Biegelsen lowered the price target on NovoCure Ltd. (NASDAQ: NVCR) to $42.00 (from $49.00) while maintaining a Overweight rating.
The analyst comments "Sizing up the brain METS market. NVCR estimates ~17K patients a year that could be... More
